Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 45Uterine Cervical Neoplasms 22Fallopian Tube Neoplasms 20Carcinoma, Ovarian Epithelial 15Neoplasms 8Endometrial Neoplasms 8Lung Neoplasms 7Breast Neoplasms 5Stomach Neoplasms 4Recurrence 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Melanoma 4Head and Neck Neoplasms 4Gestational Trophoblastic Disease 4Vulvar Neoplasms 3Peritoneal Neoplasms 3Kidney Neoplasms 3Esophageal Neoplasms 3Colorectal Neoplasms 3Uterine Neoplasms 2Sarcoma 2Lymphoma, Non-Hodgkin 2Liver Neoplasms 2Laryngeal Neoplasms 2Hydatidiform Mole 2Gynecologic Cancer 2Glioblastoma 2Colonic Neoplasms 2Cholangiocarcinoma 2

Interventions

Fulvestrant 3cobimetinib 2anlotinib 2Bevacizumab 2trametinib 1selinexor 1ribociclib 1relacorilant 1palbociclib 1osimertinib 1olaparib 1niraparib 1nintedanib 1exemestane 1enzalutamide 1dabrafenib 1atezolizumab 1alectinib 1abemaciclib 1Watchful Waiting 1Vemurafenib 1Transurethral Resection of Prostate 1Trabectedin 1Tamoxifen 1STX-478 1Pregnancy Tests 1Pemetrexed 1Metformin 1Letrozole 1Imlunestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × Drug Therapy × Gynecologic × Clear all
NCT06692166 2024-11-22

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 3 Recruiting
420 enrolled
Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡